Skip to main content
. 2024 Aug 15;16(8):3672–3686. doi: 10.4251/wjgo.v16.i8.3672

Table 1.

League table for clinical outcomes

League table










OS
HAIC + Lenv + A 0.42 (0.12; 1.44)
0.58 (0.09; 3.84) HAIC + A 0.38 (0.12; 1.17)
0.42 (0.12; 1.44) 0.73 (0.17; 3.08) HAIC + Lenv 0.52 (0.21; 1.28)
0.36 (0.05; 2.31) 0.61 (0.13; 2.93) 0.84 (0.20; 3.46) HAIC + PD-1 0.62 (0.21; 1.84)
0.24 (0.05; 1.17) 0.41 (0.12; 1.39) 0.56 (0.20; 1.56) 0.66 (0.20; 2.20) HAIC + Sora 0.43 (0.12; 1.47) 0.58 (0.36; 0.94)
0.24 (0.04; 1.63) 0.42 (0.08; 2.09) 0.58 (0.13; 2.47) 0.68 (0.14; 3.32) 1.03 (0.31; 3.43)     HAIC + RT 0.50 (0.16; 1.52)
0.22 (0.05; 1.01) 0.38 (0.12; 1.17) 0.52 (0.21; 1.28) 0.62 (0.21; 1.84) 0.94 (0.57; 1.55) 0.91 (0.29; 2.85) HAIC 0.53 (0.40; 0.70) 0.50 (0.33; 0.75) 0.32 (0.11; 0.95)
0.12 (0.03; 0.57) 0.21 (0.07; 0.67) 0.29 (0.11; 0.74) 0.34 (0.11; 1.05) 0.52 (0.33; 0.81) 0.50 (0.16; 1.52) 0.55 (0.42; 0.72) Sora
0.11 (0.01; 0.84) 0.18 (0.03; 1.10) 0.25 (0.05; 1.33) 0.30 (0.05; 1.76) 0.45 (0.10; 2.00) 0.44 (0.07; 2.66) 0.48 (0.12; 1.95) 0.88 (0.21; 3.63) HAIC + TACE + S-1 1.00 (0.35; 2.86)
0.11 (0.02; 0.63) 0.18 (0.04; 0.78) 0.25 (0.07; 0.91) 0.30 (0.07; 1.24) 0.45 (0.16; 1.29) 0.44 (0.10; 1.90) 0.48 (0.19; 1.21) 0.88 (0.34; 2.28) 1.00 (0.35; 2.86) HAIC + TACE 1.03 (0.45; 2.34)
0.11 (0.02; 0.53) 0.19 (0.06; 0.63) 0.26 (0.10; 0.70) 0.31 (0.10; 0.99) 0.47 (0.24; 0.90) 0.45 (0.13; 1.52) 0.50 (0.33; 0.75) 0.90 (0.55; 1.47) 1.03 (0.27; 3.91) 1.03 (0.45; 2.34) TACE
0.07 (0.01; 0.46) 0.12 (0.03; 0.58) 0.17 (0.04; 0.68) 0.20 (0.04; 0.92) 0.30 (0.09; 0.99) 0.29 (0.06; 1.40) 0.32 (0.11; 0.95) 0.58 (0.19; 1.77) 0.66 (0.11; 3.87) 0.66 (0.16; 2.73) 0.64 (0.20; 2.04) BSC
PFS
HAIC + A 0.49 (0.17; 1.39)
0.96 (0.17; 5.46) HAIC + Lenv + A 0.46 (0.16; 1.36)
0.85 (0.16; 4.50) 0.89 (0.13; 5.94) HAIC + TACE + S-1 0.90 (0.31; 2.59)
0.77 (0.21; 2.77) 0.80 (0.17; 3.87) 0.90 (0.31; 2.59) HAIC + TACE 0.39 (0.22; 0.70)
0.75 (0.17; 3.29) 0.78 (0.14; 4.44) 0.88 (0.17; 4.61) 0.97 (0.27; 3.50) HAIC + PD-1 0.65 (0.23; 1.85)
0.53 (0.10; 2.70) 0.55 (0.09; 3.58) 0.62 (0.10; 3.73) 0.69 (0.16; 2.94) 0.71 (0.14; 3.61) HAIC + RT 0.47 (0.14; 1.52)
0.49 (0.17; 1.39) 0.51 (0.13; 2.04) 0.57 (0.16; 2.07) 0.63 (0.30; 1.32) 0.65 (0.23; 1.85) 0.92 (0.26; 3.21) HAIC 0.91 (0.38; 2.16) 0.62 (0.39; 0.98) 0.51 (0.33; 0.78)
0.44 (0.11; 1.72) 0.46 (0.16; 1.36) 0.52 (0.11; 2.45) 0.57 (0.18; 1.80) 0.59 (0.15; 2.30) 0.84 (0.18; 3.83) 0.91 (0.38; 2.16) HAIC + Lenv
0.39 (0.11; 1.32) 0.40 (0.09; 1.86) 0.45 (0.11; 1.91) 0.50 (0.19; 1.34) 0.52 (0.15; 1.76) 0.73 (0.20; 2.61) 0.79 (0.42; 1.51) 0.87 (0.30; 2.57) HAIC + Sora 0.64 (0.40; 1.03)
0.30 (0.10; 0.95) 0.31 (0.07; 1.36) 0.35 (0.11; 1.18) 0.39 (0.22; 0.70) 0.40 (0.13; 1.26) 0.57 (0.15; 2.16) 0.62 (0.39; 0.98) 0.68 (0.26; 1.82) 0.78 (0.36; 1.72) TACE
0.25 (0.08; 0.77) 0.26 (0.06; 1.10) 0.29 (0.07; 1.12) 0.32 (0.14; 0.75) 0.33 (0.11; 1.02) 0.47 (0.14; 1.52) 0.51 (0.33; 0.78) 0.56 (0.21; 1.47) 0.64 (0.40; 1.03) 0.82 (0.44; 1.53) Sora
CR
HAIC + Sora 6.21 (0.28; 138.56) 6.77 (2.11; 21.68)
1.46 (0.02; 90.79) HAIC + PD-1 1.82 (0.04; 92.69)
2.27 (0.22; 22.94) 1.55 (0.02; 123.86) HAIC + TACE + S-1 1.10 (0.26; 4.62)
2.49 (0.41; 15.27) 1.70 (0.03; 106.73) 1.10 (0.26; 4.62) HAIC + TACE 3.30 (1.20; 9.03)
2.66 (0.75; 9.46) 1.82 (0.04; 92.69) 1.17 (0.17; 8.14) 1.07 (0.29; 3.91) HAIC 1.93 (0.09; 42.76) 2.13 (0.32; 14.10) 3.01 (1.41; 6.41) 3.08 (1.36; 6.98)
5.15 (0.18; 146.19) 3.52 (0.02; 524.16) 2.27 (0.06; 87.52) 2.07 (0.07; 59.37) 1.93 (0.09; 42.76) BSC
5.67 (0.58; 55.24) 3.87 (0.05; 303.50) 2.50 (0.17; 37.42) 2.27 (0.23; 22.55) 2.13 (0.32; 14.10) 1.10 (0.03; 41.42) HAIC + Lenv
7.62 (2.55; 22.77) 5.21 (0.10; 283.99) 3.36 (0.42; 26.67) 3.06 (0.69; 13.61) 2.86 (1.37; 5.98) 1.48 (0.06; 35.69) 1.35 (0.18; 10.25) Sora
8.21 (1.82; 37.10) 5.62 (0.10; 310.71) 3.62 (0.63; 20.94) 3.30 (1.20; 9.03) 3.08 (1.36; 6.98) 1.59 (0.06; 39.20) 1.45 (0.18; 11.38) 1.08 (0.36; 3.24) TACE
PR
HAIC + TACE + S-1 2.34 (0.86; 6.40)
1.59 (0.42; 6.00) HAIC + Lenv 1.54 (0.92; 2.56)
1.72 (0.44; 6.65) 1.08 (0.50; 2.33) HAIC + PD-1 1.42 (0.80; 2.51)
2.34 (0.86; 6.40) 1.48 (0.62; 3.53) 1.36 (0.55; 3.37) HAIC + TACE 2.16 (1.14; 4.08)
2.42 (0.61; 9.51) 1.52 (0.69; 3.37) 1.41 (0.61; 3.23) 1.03 (0.41; 2.62) HAIC + Sora 5.00 (1.19; 21.04) 4.50 (2.71; 7.48)
2.44 (0.72; 8.32) 1.54 (0.92; 2.56) 1.42 (0.80; 2.51) 1.04 (0.51; 2.11) 1.01 (0.55; 1.85) HAIC 2.07 (1.54; 2.80) 4.62 (0.24; 89.16) 6.32 (4.08; 9.80)
5.05 (1.54; 16.61) 3.18 (1.76; 5.76) 2.94 (1.55; 5.59) 2.16 (1.14; 4.08) 2.09 (1.06; 4.12) 2.07 (1.54; 2.80) TACE
11.28 (0.46; 277.69) 7.10 (0.35; 143.15) 6.56 (0.32; 133.57) 4.81 (0.23; 100.83) 4.67 (0.23; 95.70) 4.62 (0.24; 89.16) 2.23 (0.11; 43.69) BSC
13.29 (3.63; 48.61) 8.37 (4.32; 16.23) 7.73 (3.81; 15.68) 5.67 (2.49; 12.89) 5.50 (3.40; 8.89) 5.45 (3.57; 8.30) 2.63 (1.57; 4.41) 1.18 (0.06; 23.41) Sora
ORR
HAIC + TACE + S-1 1.99 (0.40; 9.99)
1.28 (0.12; 14.33) HAIC + Lenv 1.95 (0.51; 7.44)
1.76 (0.15; 21.24) 1.37 (0.19; 10.05) HAIC + PD-1 1.42 (0.33; 6.19)
1.96 (0.21; 18.19) 1.53 (0.29; 7.97) 1.11 (0.19; 6.47) HAIC + Sora 8.00 (1.08; 59.18) 6.08 (2.38; 15.59)
1.99 (0.40; 9.99) 1.55 (0.26; 9.34) 1.13 (0.17; 7.53) 1.02 (0.22; 4.74) HAIC + TACE 3.97 (1.43; 11.04)
2.50 (0.34; 18.61) 1.95 (0.51; 7.44) 1.42 (0.33; 6.19) 1.28 (0.48; 3.37) 1.26 (0.38; 4.15) HAIC 1.93 (0.07; 56.84) 3.16 (1.71; 5.85) 8.36 (4.66 15.01)
4.84 (0.09; 246.61) 3.77 (0.10; 143.00) 2.74 (0.07; 109.59) 2.47 (0.07; 83.18) 2.43 (0.07; 87.58) 1.93 (0.07; 56.84) BSC
7.91 (1.17; 53.36) 6.16 (1.41; 26.89) 4.48 (0.91; 22.12) 4.04 (1.28; 12.73) 3.97 (1.43; 11.04) 3.16 (1.71; 5.85) 1.63 (0.05; 50.80) TACE
17.88 (2.22; 143.80) 13.92 (3.25; 59.60) 10.14 (2.09; 49.09) 9.13 (3.87; 21.51) 8.97 (2.39; 33.65) 7.15 (4.06; 12.58) 3.70 (0.12; 113.89) 2.26 (0.98; 5.22) Sora
DCR
HAIC + TACE + S-1 2.04 (0.55; 7.61)
1.17 (0.15; 9.35) HAIC + PD-1 2.52 (0.72; 8.81)
2.04 (0.55; 7.61) 1.74 (0.35; 8.65) HAIC + TACE 3.87 (1.64; 9.11)
2.95 (0.56; 15.45) 2.52 (0.72; 8.81) 1.45 (0.53; 3.94) HAIC 1.40 (0.45; 4.37) 0.06 (0.00; 1.40) 1.71 (0.33; 8.88) 2.67 (1.59; 4.50) 3.02 (2.08; 4.40)
4.14 (0.56; 30.84) 3.53 (0.65; 19.15) 2.03 (0.45; 9.24) 1.40 (0.45; 4.37) HAIC + Lenv
4.38 (0.71; 26.90) 3.73 (0.87; 16.04) 2.15 (0.62; 7.49) 1.48 (0.70; 3.13) 1.06 (0.27; 4.11) HAIC + Sora 1.68 (0.86; 3.29)
5.05 (0.49; 52.13) 4.30 (0.54; 34.07) 2.47 (0.36; 17.01) 1.71 (0.33; 8.88) 1.22 (0.16; 9.01) 1.15 (0.19; 7.03) BSC
7.89 (1.64; 37.97) 6.73 (1.73; 26.11) 3.87 (1.64; 9.11) 2.67 (1.59; 4.50) 1.90 (0.55; 6.64) 1.80 (0.73; 4.48) 1.56 (0.28; 8.79) TACE
8.52 (1.56; 46.49) 7.26 (1.97; 26.84) 4.18 (1.43; 12.17) 2.89 (1.99; 4.19) 2.06 (0.62; 6.80) 1.95 (1.01; 3.75) 1.69 (0.31; 9.14) 1.08 (0.57; 2.05) Sora

HAIC: Hepatic arterial infusion chemotherapy; Sora: Sorafenib; Lenv: Lenvatinib; TACE: Transarterial chemoembolization; RT: Radiotherapy; S-1: A composite preparation of a 5-fluorouracil prodrug; A: Ablation; PD-1: Programmed death 1; BSC: Best supportive care.